Aclaris Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $160.5M
Liabilities Breakdown FY2025
Total Liabilities: $57.4M
Asset Breakdown
Total Assets: $160.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $20.0M | 12.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $761.0K | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $139.7M | 87.1% |
Liabilities Breakdown
Total Liabilities: $57.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $13.2M | 22.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $44.2M | 77.1% |